Create your Personal Health Record and unlock support built around you

Aligned with your diagnosis, treatment and where you are in your care. It lets HealthTree show you:

Treatments and trials you qualify for
Education for your stage of care
Financial support for your medications
Solutions to your side effects

Learn more about HealthTree

AML EHA Update

Name: AML EHA Update
Start: 2026-08-20T11:00:00-04:00
End: 2026-08-20T12:00:00-04:00

Aug 20, 2026

11:00AM - 12:00PM EDT

Online Event

Overview

Join HealthTree as we learn about the newest developments in AML presented at the European Hematology Association this year! Dr. Shivani Handa will discuss not only her research in Azacitidine and Venetoclax for older AML patients, but also AML clinical updates you will not want to miss!

Agenda

11:00 AM

Introduction

Eliza Prickett, MPH

Eliza introduces the agenda of the event and our featured speaker Dr. Shivani Handa

11:05 AM

Presentation

Dr. Shivani Handa

Dr. Handa shares the latest updated on AML

11:35 AM

Questions and Answers

Audience

Come with your questions and we'll answer them!

Speakers & Moderators

Eliza Prickett, MPH

Eliza joined HealthTree in March 2026 as the Leukemia Patient Health Education Manager. Prior to joining HealthTree, she completed a Master’s Degree in Public Health from Brigham Young University and worked with a variety of underserved populations in government and healthcare settings, including Americorps and Utah Health Department. When not in office, Eliza enjoys reading, writing and learning new things about the world.

Dr. Shivani Handa

As a hematologist, Dr. Handa specialize in caring for patients with various blood cancers and disorders, such as leukemia, myelodysplastic syndromes and myeloproliferative neoplasms. Dr. Handa's scholarly work focuses on clinical research and drug development in patients with myeloid malignancies, with an emphasis on myeloproliferative neoplasms (MPNs), acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). As a member of Beat-AML and MPN research consortium, my colleagues and I strive to develop novel clinical trials. My research has been published in prestigious peer-reviewed journals, such as Blood, Blood Advances, Leukemia and JCO Precision Oncology.